Antiproliferative effects of somatostatin analogs in endocrine tumours
Open Access
- 8 May 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (40)
- https://doi.org/10.3410/m1-40
Abstract
Antiproliferative effects of somatostatin analogs in endocrine tumoursThis publication has 33 references indexed in Scilit:
- Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin AnaloguesJournal of Clinical Endocrinology & Metabolism, 2009
- In vitro testing of new somatostatin analogs on pituitary tumor cellsMolecular and Cellular Endocrinology, 2008
- AcromegalyEndocrinology and Metabolism Clinics of North America, 2008
- Rapid Pituitary Tumor Shrinkage with Dissociation between Antiproliferative and Antisecretory Effects of a Long-Acting Octreotide in an Acromegalic PatientJournal of Clinical Endocrinology & Metabolism, 2007
- Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: Preferential expression of somatostatin receptor subtype 3Journal of Endocrinological Investigation, 2006
- Resistance to somatostatin analogs in acromegaly: An evolving concept?Journal of Endocrinological Investigation, 2006
- Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.2005
- Somatostatin Receptor-Specific Analogs: Effects on Cell Proliferation and Growth Hormone Secretion in Human Somatotroph Tumors1Journal of Clinical Endocrinology & Metabolism, 2001
- Signal transduction of somatostatin receptors negatively controlling cell proliferationJournal of Physiology-Paris, 2000
- Prediction of efficacy of octreotide therapy in patients with acromegaly.Journal of Clinical Endocrinology & Metabolism, 1996